Health & Medical Diabetes

Neck Circumference as Predictor of Cardio-Metabolic Syndrome

Neck Circumference as Predictor of Cardio-Metabolic Syndrome

Results


The anthropometric and metabolic characteristics of the participants by gender are presented in Table 1 . The 4201 subjects had a mean age of 43.7±12.0 years (men: 44.1±12.4, women: 43.1±11.3 years), mean BMI of 23.73±3.15 kg/m (men: 24.44±2.98, women: 22.67±3.10 kg/m) and mean WC and NC of 82.37±10.08 cm (men: 86.44±8.71, women: 76.36±8.88 cm) and 35.41±3.39 (men: 37.40±2.46, women: 32.46±2.24 cm), respectively. Of the 4201 subjects, MS was diagnosed in 443 men (17.66%) and 215 women (12.70%). High BP was diagnosed in 965 men (38.48%) and 429 women (25.34%). Increased FBG was found in 349 (13.92%) men and 150 (8.86%) women. Increased TG was found in 972 men (38.76%) and 287 women (16.95%). Decreased HDL-C was found in 646 men (25.76%) and 471 women (27.82%). Increased LDL-C was detected in 1395 men (55.62%) and 743 women (43.89%). Increased TC was detected in 1633 men (65.11%) and 1044 women (61.79%).

The partial correlations between cardio-metabolic risk factors and anthropometry indices by gender are shown in Table 2 . In male subjects, after adjusting for age, the NC revealed a positive correlation with SBP and DBP (r=0.250 and 0.261, both P<0.01), FBG (r=0.177, P<0.01), TG (r=0.240, p<0.01), TC (r=0.143, p<0.01) and LDL-C (r=0.088, p<0.01). In contrast, NC was negatively correlated with HDL-C (r=-0.202, p<0.01). Similarly, in female subjects, NC showed the same trend in the correlation with cardio-metabolic risk factors, with the exception of TC. The correlations of other anthropometric indices to the cardio-metabolic risk factors were the same as those of NC to the cardio-metabolic risk factors in both genders.

The areas under the ROC curves (AUCs) were constructed to evaluate the predictive values of anthropometric indices for cardio-metabolic risks ( Table 3 ). The AUCs of NC were 0.635 and 0.659 for the risk factor of BP, 0.659 and 0.678 for TG, 0.618 and 0.641 for HDL-C, 0.624 and 0.646 for glucose, 0.558 and 0.596 for LDL-C and 0.683 and 0.703 for MS-rf in men and women, respectively. An NC of ≥37 cm for men and ≥33 cm for women were the best values of combined sensitivity and specificity in identifying MS. The AUCs of NC for all cardio-metabolic risk factors, except BMI for glucose in men and BMI for HDL-C in women, were lower than those of other anthropometric measurements, including WC, BMI and WHpR.

The crude and adjusted ORs for the cardio-metabolic risk factors for per SD increase in NC are presented in Figure 1 Generally, greater NC was linearly associated with higher risk of metabolic abnormalities in both genders. Women tended to have closer associations than men. Based on the univariate logistic regression analysis with MS-rf as the dependent variable, the crude OR was 2.03 (95% CI: 1.84–2.23) in men and 2.03 (95% CI: 1.79–2.29) in women (p<0.01 in both).



(Enlarge Image)



Figure 1.



Gender-specific odds ratios (ORs) and 95% confidence intervals (95% CIs) of cardio-metabolic risk factors for neck circumference (NC). OR: unadjusted, OR: adjusted for age, OR: adjusted for age, BMI, WC and WHpR.





After adjusting for age, NC was significantly associated with MS-rf at ORs 2.06 in men and 1.88 in women (P<0.01 in both). With further adjustments for BMI, WC and WHpR, the significant associations remained between NC and MS-rf with ORs of 1.29 in men and 1.44 in women (P<0.01 in both). In the multivariate model including age, BMI, WC and WHpR, NC also showed obvious correlations with the occurrence of high BP (OR, 1.15 in men and 1.22 in women), increased TG (OR, 1.16 in men and 1.42 in women), increased FBP (OR, 1.26 in men and 1.32 in women) and decreased HDL-C (OR, 1.29 in women). We also made the adjustments for anthropometric indices (BMI, WC and WHpR) one by one due to close colinearity among them, similar results were found to those observed in the previous multivariate model included all of them (data not shown).

SHARE
RELATED POSTS on "Health & Medical"
New Information on Type 2 Diabetes
New Information on Type 2 Diabetes
Type 2 Diabetes - Preventing Gestational Diabetes
Type 2 Diabetes - Preventing Gestational Diabetes
Diabetes 2 Treatment- A Time to Act
Diabetes 2 Treatment- A Time to Act
FDA Approves New Diabetes Drug Symlin
FDA Approves New Diabetes Drug Symlin
About Insulin
About Insulin
Gestational Diabetes Diet Plan
Gestational Diabetes Diet Plan
How To Treat Focal Segmental Glomerulosclerosis (fsgs) Effectively
How To Treat Focal Segmental Glomerulosclerosis (fsgs) Effectively
Study Explains Why Diabetics Face High Risk From Angioplasty
Study Explains Why Diabetics Face High Risk From Angioplasty
Diabetic Testing Supplies
Diabetic Testing Supplies
Diabetes - 5 Ways to Save Money on Medicine
Diabetes - 5 Ways to Save Money on Medicine
Diabetes and Exercise
Diabetes and Exercise
Use of U-500 Insulin in Continuous Subcutaneous Insulin Infusion
Use of U-500 Insulin in Continuous Subcutaneous Insulin Infusion
Alternative Health - 7 Tips to Help With Your Weight Loss and Type 2 Diabetes
Alternative Health - 7 Tips to Help With Your Weight Loss and Type 2 Diabetes
A Guide to Symptoms of Diabetes
A Guide to Symptoms of Diabetes
Type 2 Diabetes Treatment Victoza Helps Type 1, Too
Type 2 Diabetes Treatment Victoza Helps Type 1, Too
Blood Sugar Level
Blood Sugar Level
What is Monavie?
What is Monavie?
Diabetic Muscle Infarction: A Systematic Review
Diabetic Muscle Infarction: A Systematic Review
How Is an Epidemiological Study Carried Out?
How Is an Epidemiological Study Carried Out?
We Can Change the Natural History of Type 2 Diabetes
We Can Change the Natural History of Type 2 Diabetes

Leave Your Reply

*